|
|
Item Number: 11822 correct answer: 4 category: Antihyperlipidemics
1. An agent primarily used to decrease triglycerides is:
1. lovastatin
2. neomycin
3. cholestyramine
4. gemfibrozil
5. probucol
Item Number: 11824 correct answer: 5 category: Antihyperlipidemics
2. Gallstones, abdominal pain and myalgia are side effects of:
1. colestipol
2. probucol
3. lovastatin
4. nicotinic acid
5. clofibrate
Item Number: 11836 correct answer: 4 category: Antihyperlipidemics
3. Correct statements regarding the effects of lipid lowering agents on serum
lipids include:
1. nicotinic acid reduces VLDL triglycerides only
2. probucol increases HDL
3. neomycin increases LDL cholesterol
4. clofibrate primarily decreases VLDL triglycerides
5. lovastatin decreases HDL
Item Number: 11418 correct answer: 3 category: Antihyperlipidemics
4. Drugs which indirectly enhance the activity of the hepatic enzyme HMG CoA
reductase include:
1. probucol
2. D-thyroxine
3. cholestyramine
4. lovastatin
5. gemfibrozil
Item Number: 11821 correct answer: 1 category: Antihyperlipidemics
5. Agents primarily used to treat hypercholesterolemia which work by inhibiting
the HMG-CoA reductase enzyme include:
1. lovastatin
2. gemfibrozil
3. niacin
4. clofibrate
5. colestipol
Item Number: 11413 correct answer: 4 category: Antihyperlipidemics
6. Niacin is a hypolipidemic drug which has several adverse effects.
Administration of an aspirin 30 minutes prior to a dose reduces the likelihood
of:
1. elevated hepatic enzymes
2. diarrhea
3. acanthosis nigricans
4. cutaneous flushing
5. myositis
Item Number: 11826 correct answer: 5 category: Antihyperlipidemics
7. Side effects of niacin include:
1. flushing
2. hyperglycemia
3. jaundice
4. hyperuricemia
5. All of the above
Item Number: 11838 correct answer: 2 category: Antihyperlipidemics
8. The agent which is thought to lower triglycerides by inhibiting hepatic VLDL
secretion and suppressing VLDL synthesis is:
1. neomycin
2. nicotinic acid
3. fluvastatin
4. colestipol
5. beta sitosterol
|
|